Adrián Jesús Santoyo Rojas

Adrián Jesús Santoyo Rojas

Auto-generated profile, based on publicly available information

Adrián Jesús Santoyo Rojas

Benemérita Universidad Autónoma de Puebla

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2025 in International Science Journal
Verified
Journal Article
Open access
PDF file
EBEmerson Javier García Ballesteros
Emerson Javier García Ballesteros
RRRuddy Solange García Rosero
Ruddy Solange García Rosero
HMHillary Yahiry Mejía Montiel
Hillary Yahiry Mejía Montiel
PHPablo Isaac Vera Heredia
Pablo Isaac Vera Heredia
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
AGAngie Lizbeth Farías García
Angie Lizbeth Farías García
This study analyzes the impact of artificial intelligence (AI) on diagnostic accuracy and clinical decision-making in internal medicine across Mexico, Colombia, and Ecuador. The objective was to evaluate how AI technologies are transforming diagnostic processes, improving efficiency, and shaping ethical and institutional frameworks in Latin American healthcare systems. A comparative analytical design based on the Scientific Method was employed, integrating data from literature reviews, institutional documents, and expert consultations. The methodology followed five phases: observation, hypothesis formulation, data collection, process-based analysis, and validation. Results indicate a significant positive impact of AI on diagnostic accuracy (+23% regional average), reduction of diagnostic time (−25%), and improved decision-making efficiency (+27%). Mexico demonstrated the highest adoption rate, with strong regulatory frameworks and professional training programs; Colombia showed intermediate progress driven by academic–industrial collaboration; and Ecuador presented early adoption stages, primarily supported by international partnerships. Ethical and regulatory readiness was highest in Mexico (83%), moderate in Colombia (69%), and emerging in Ecuador (57%), reflecting disparities in governance and digital infrastructure. Institutional barriers identified include limited funding, data fragmentation, and resistance to change, while key facilitators involve education, collaboration, and regulatory maturity. The study concludes that AI is transforming internal medicine into a predictive, data-driven, and ethically guided discipline. Sustainable progress requires investment in infrastructure, physician training, and regional cooperation to ensure equitable, transparent, and human-centered implementation of AI in clinical practice.

30 October 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
RORafael Rodriguez Ornelas
Rafael Rodriguez Ornelas
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
PMPaulina Gutiérrez Medina
Paulina Gutiérrez Medina
JAJosé Enrique González Araujo
José Enrique González Araujo
GVGeamiléy Anggeline Atencio Valdez
Geamiléy Anggeline Atencio Valdez
LLLuis Fernando Jimenez Lopez
Luis Fernando Jimenez Lopez
Alzheimer’s disease (AD) represents one of the most complex neurodegenerative disorders, demanding a transition from symptom-based management toward biologically informed, patient-centered precision medicine. This review analyzes recent advances in molecular biomarkers, proteomic profiling, and monoclonal antibody therapies, integrating global evidence and expert consensus from Mexico, Colombia, and Ecuador. A systematic analysis of 24 high-impact studies published between 2018 and 2025 demonstrated that plasma and CSF biomarkers—especially p-tau217, p-tau181, and proteomic signatures—provide exceptional accuracy for early diagnosis and disease staging, surpassing traditional clinical criteria. Evidence from phase 3 trials with lecanemab and donanemab confirmed that amyloid-targeted therapies can significantly slow cognitive and functional decline when guided by validated biomarkers. Complementary Delphi consensus findings revealed strong expert agreement on adopting p-tau217 as a first-line test, incorporating APOE genotyping and MRI safety monitoring, and ensuring ethical and equitable implementation of precision medicine in Latin America. This review concludes that Alzheimer’s research is undergoing a paradigm shift toward molecular definition, individualized therapy, and ethically responsible innovation. Future efforts should focus on expanding biomarker validation in diverse populations, integrating artificial intelligence for real-time monitoring, and reinforcing multidisciplinary education. Precision medicine thus represents not only a scientific advance but also an ethical and social commitment to global equity in dementia care.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
JAJorge Ozziel Badillo Avalos
Jorge Ozziel Badillo Avalos
CBCesar Emmanuel Abarca Becerril
Cesar Emmanuel Abarca Becerril
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
SMSantiago Xavier Bucheli Machado
Santiago Xavier Bucheli Machado
MCMadelayne Cecilia Enriquez Cobos
Madelayne Cecilia Enriquez Cobos
LNLuis Gabriel Beltran Narvaez
Luis Gabriel Beltran Narvaez
Upper airway disorders are traditionally approached as localized conditions affecting the nasal cavity, paranasal sinuses, pharynx, and related structures. However, accumulating evidence indicates that these disorders exert clinically meaningful systemic effects through interconnected physiological, inflammatory, and neurohumoral mechanisms. This narrative integrative review examines the systemic clinical implications of major upper airway disorders, including obstructive sleep apnea, allergic rhinitis, chronic rhinosinusitis, and tonsillopharyngitis. The analysis integrates epidemiological data, mechanistic insights, and clinical outcome evidence to characterize how upper airway dysfunction contributes to cardiovascular disease, metabolic dysregulation, neurocognitive impairment, immune and inflammatory alterations, and lower-airway comorbidity. The findings highlight distinct systemic association profiles across conditions: obstructive sleep apnea demonstrates strong links with cardiovascular, metabolic, and neurocognitive domains, whereas allergic rhinitis and chronic rhinosinusitis are more closely associated with immune-mediated pathways and lower-airway disease within the unified airway framework. Tonsillopharyngitis shows a more focused inflammatory profile with limited multisystem extension. Collectively, the evidence supports a systems-based perspective in which upper airway disorders are understood as modifiers of systemic health rather than isolated local diseases. This integrative approach has important implications for medical education, interdisciplinary clinical practice, and early identification of systemic risk, particularly in healthcare contexts with high burdens of chronic disease.

3 November 2025 in IECCMEXICO
Verified
Journal Article
Closed access
DMDulce Rocío Flores Montiel
Dulce Rocío Flores Montiel
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
TSTiffany Ivanna Guerrero Solórzano
Tiffany Ivanna Guerrero Solórzano
SPSilvana Cabrera Puentes
Silvana Cabrera Puentes
EEErwin Giovanny Mercado Estrada
Erwin Giovanny Mercado Estrada
ANAlexa Fernanda Uriostegui Navarro
Alexa Fernanda Uriostegui Navarro
Childhood obesity has emerged as a critical global health challenge with growing prevalence across Latin America, particularly in Mexico, Colombia, and Ecuador. This review synthesizes current international evidence on the biological, behavioral, and policy determinants of obesity and evaluates preventive strategies within clinical, educational, and governmental frameworks. Data reveal that fewer than one in five children meet physical activity guidelines, while sugar-sweetened beverage (SSB) consumption and inadequate sleep remain pervasive contributors to metabolic risk. Family-based behavioral programs with at least 26 contact hours and multicomponent school interventions—including daily physical activity, canteen reform, and sleep literacy—produce the most consistent reductions in BMI z-scores and metabolic markers. Fiscal and regulatory measures, such as SSB taxation and front-of-package labeling, complement these interventions by reshaping food environments and reducing health inequities when properly enforced. The integrated Clinic–School–Home–Policy framework proposed in this study offers a sustainable model that aligns individual behavior with supportive environments and governance mechanisms. Long-term success depends on cross-sector collaboration, continuous evaluation, and social participation to ensure equitable access to healthy food, safe physical activity, and sleep-promoting routines. By transforming policy and practice into a unified prevention ecosystem, Latin American nations can reverse current trends and safeguard the health and well-being of the next generation.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
ASAbril Samantha Hernández Silva
Abril Samantha Hernández Silva
EVElizabeth Contreras Vargas
Elizabeth Contreras Vargas
DPDiego Xavier Aráuz Paredes
Diego Xavier Aráuz Paredes
HHHenry Alexander García Hernández
Henry Alexander García Hernández
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
YCYuly Andrea Márquez Castañeda
Yuly Andrea Márquez Castañeda
Gynecologic health has traditionally been approached through a reproductive-centered lens; however, growing international evidence demonstrates that gynecologic conditions, hormonal transitions, and interventions exert significant systemic and long-term clinical effects across the female lifespan. This narrative review synthesizes high-impact literature addressing gynecologic health beyond reproductive function, with particular emphasis on metabolic, cardiovascular, endocrine, immune-inflammatory, genitourinary, and oncologic outcomes. Chronic conditions such as polycystic ovary syndrome and endometriosis are examined as early and midlife determinants of long-term systemic risk, while menopause is analyzed as a critical biological transition influencing cardiometabolic health. The review also explores the long-term implications of gynecologic surgery, hormonal contraception, and menopausal hormone therapy, highlighting the complexity and context-dependence of associated risks and benefits. By adopting a life-course and systems-based perspective, this article underscores the importance of integrating gynecologic history into comprehensive risk assessment, preventive strategies, and medical education. The findings support a reframing of gynecology as a foundational component of women’s overall health, with relevance across diverse healthcare settings, including Mexico, Colombia, and Ecuador.

27 December 2025 in IECCMEXICO
Verified
Journal Article
Closed access
AHAlexis Ramírez Hernández
Alexis Ramírez Hernández
JCJosé Arnulfo Perez Carrillo
José Arnulfo Perez Carrillo
JMJuan Diego Paloma Meza
Juan Diego Paloma Meza
ARAdrián Jesús Santoyo Rojas
Adrián Jesús Santoyo Rojas
PMPatricio Sebastian Ordóñez Montalvo
Patricio Sebastian Ordóñez Montalvo
ZMZuleika Morales
Zuleika Morales
Tumor adaptation and therapeutic resistance represent major limitations to sustained treatment efficacy in modern oncology. Despite advances in targeted therapies and personalized approaches, disease progression and relapse remain frequent, reflecting the intrinsic biological complexity of malignant tumors. This review synthesizes high-impact evidence addressing the mechanisms that drive tumor adaptation under therapeutic pressure, with particular emphasis on intratumoral heterogeneity, evolutionary dynamics, and cellular plasticity. The analyzed literature supports the view of cancer as a dynamic and evolving ecosystem composed of genetically and phenotypically diverse subpopulations that respond heterogeneously to treatment. Resistance emerges as a predictable consequence of Darwinian selection, shaped by both genetic alterations and non-genetic adaptive processes, including reversible drug-tolerant states and microenvironmental influences. The findings further highlight the limitations of static, single-time-point molecular profiling in capturing tumor complexity and guiding long-term therapeutic decisions. Evolution-informed strategies, such as adaptive therapy and rational treatment sequencing, are discussed as biologically grounded approaches that may improve disease control by managing, rather than attempting to eradicate, heterogeneous tumor populations. This integrative perspective is particularly relevant for diverse healthcare settings, including those in Latin America, where conceptual frameworks can support clinical decision-making in variable resource contexts. Overall, understanding tumor adaptation and resistance as emergent evolutionary phenomena provides a coherent foundation for advancing personalized oncology, improving clinical reasoning, and strengthening oncology education